Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase IIA Lorico, B H LongTumori|February 29, 1988
Changes in chemosensitivity of K 562 leukemia cells after induction of erythroid differentiation by heminG Toffoli, A Lorico, M BoiocchiInternational Journal of Cancer|December 2, 1992
Novobiocin-induced accumulation of etoposide (VP-16) in WEHI-3B D+ leukemia cellsA Lorico, G Rappa, A C SartorelliInternational Journal of Cancer|July 9, 1992
Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26)G Rappa, A Lorico, A C SartorelliCancer Research|May 15, 1992
Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugsG Rappa, A Lorico, A C SartorelliCancer Research|October 15, 1990
Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase IIG Rappa, A Lorico, A C SartorelliCancer Research|November 15, 1993
Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocinG Rappa, A Lorico, A C SartorelliEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolinE Erba, S Sen, A Lorico, et al.Acta Europaea Fertilitatis|May 1, 1983
Modulation of lymphocyte response by hormonesR Cocchiara, A Lorico, E Cefalù, et al.Biochemical Pharmacology|July 21, 1999
New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout modelsG Rappa, R A Finch, A C Sartorelli, et al.Pageof 4